ADD ON: Sartans to Slow Alzheimer's Disease: A Randomized, Open-Label, Head-to-Head, Proof-of-Concept Study of Angiotensin Receptor Blockers Versus ACE Inhibitors in Hypertensive Mild-Moderate AD Patients using Ventricular Enlargement as Primary Outcome

Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
Sandra
Principal Investigator Last Name
Black
Awardee Organization
Contact PI Country
Project Detail
Funding Opportunity Announcement
FY Overall Cost
$450,000
Funding Organization
Agency/Funding Organization
Funding Organization Country